دورية أكاديمية
أعرض في EDS

Subtractive proteomics analysis to uncover the potent drug targets for distinctive drug design of Candida auris .

التفاصيل البيبلوغرافية
العنوان: Subtractive proteomics analysis to uncover the potent drug targets for distinctive drug design of Candida auris .
المؤلفون: Bappy MNI; Faculty of Biotechnology and Genetic Engineering, Sylhet Agricultural University, Sylhet-3100, Bangladesh.; Department of Animal and Fish Biotechnology, Sylhet Agricultural University, Sylhet-3100, Bangladesh., Robin TB; Faculty of Biotechnology and Genetic Engineering, Sylhet Agricultural University, Sylhet-3100, Bangladesh., Prome AA; Faculty of Biotechnology and Genetic Engineering, Sylhet Agricultural University, Sylhet-3100, Bangladesh., Patil RB; Department of Pharmaceutical Chemistry, Sinhgad Technical Education Society's, Sinhgad College of Pharmacy, Off Sinhgad Road, Vadgaon (Bk), Pune 411041, Maharashtra, India., Moin AT; Department of Genetic Engineering and Biotechnology, Faculty of Biological Sciences, University of Chittagong, Chattogram, Bangladesh., Akter R; Department of Biochemistry and Molecular Biology, Faculty of Biological Sciences, University of Chittagong, Chattogram, Bangladesh., Laskar FS; Faculty of Biotechnology and Genetic Engineering, Sylhet Agricultural University, Sylhet-3100, Bangladesh., Roy A; Faculty of Biotechnology and Genetic Engineering, Sylhet Agricultural University, Sylhet-3100, Bangladesh., Akter H; Faculty of Biotechnology and Genetic Engineering, Sylhet Agricultural University, Sylhet-3100, Bangladesh.; Department of Biochemistry and Chemistry, Sylhet Agricultural University, Sylhet-3100, Bangladesh., Zinnah KMA; Faculty of Biotechnology and Genetic Engineering, Sylhet Agricultural University, Sylhet-3100, Bangladesh.; Department of Animal and Fish Biotechnology, Sylhet Agricultural University, Sylhet-3100, Bangladesh.
المصدر: Heliyon [Heliyon] 2023 Jun 06; Vol. 9 (6), pp. e17026. Date of Electronic Publication: 2023 Jun 06 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: London : Elsevier Ltd, [2015]-
مستخلص: Candida auris is a serious health concern of the current world that possesses a serious global health threat and is emerging at a high rate. Available antifungal drugs are failing to combat this pathogen as they are growing resistant to those drugs and some strains have already shown resistance to all three available antifungal drugs in the market. Hence, finding alternative therapies is essential for saving lives from this enemy. To make the development of new treatments easier, we conducted some in silico study of this pathogen to discover possible targets for drug design and also recommended some possible metabolites to test in vivo circumstances. The complete proteome of the representative strain was retrieved, and the duplicate, non-essential, human homologous, non-metabolic, and druggable proteins were then eliminated. As a result, out of a total of 5441  C. auris proteins, we were able to isolate three proteins (XP 028890156.1, XP 028891672.1, and XP 028891858.1) that are crucial for the pathogen's survival as well as host-non-homolog, metabolic, and unrelated proteins to the human microbiome. Their subcellular locations and interactions with a large number of proteins (10 proteins) further point to them being good candidates for therapeutic targets. Following in silico docking of 29 putative antifungals of plant origin against the three proteins we chose, Caledonixanthone E, Viniferin, Glaucine, and Jatrorrhizine were discovered to be the most effective means of inhibiting those proteins since they displayed higher binding affinities (ranging from -28.97 kcal/mol to -51.99 kcal/mol) than the control fluconazole (which ranged between -28.84 kcal/mol and -41.15 kcal/mol). According to the results of MD simulations and MM-PBSA calculations, Viniferin and Caledonixanthone E are the most effective ligands for the proteins XP 028890156.1, XP 028891672.1, and XP 028891858.1. Furthermore, they were predicted to be safe and also showed proper ADME properties.
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(© 2023 The Authors.)
References: Curr Protein Pept Sci. 2018;19(10):948-957. (PMID: 28847290)
Proteins. 2006 Aug 15;64(3):643-51. (PMID: 16752418)
Bioinformation. 2017 Apr 30;13(4):116-121. (PMID: 28539733)
Microb Pathog. 2019 Dec;137:103731. (PMID: 31509762)
J Theor Biol. 2010 Jan 21;262(2):284-94. (PMID: 19833135)
Lett Appl Microbiol. 2018 Jan;66(1):2-13. (PMID: 29112282)
J Chem Theory Comput. 2008 Jan;4(1):116-22. (PMID: 26619985)
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41. (PMID: 11517324)
J Chem Inf Model. 2014 Jul 28;54(7):1951-62. (PMID: 24850022)
Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. (PMID: 21059682)
Protein Sci. 1993 Sep;2(9):1511-9. (PMID: 8401235)
Nucleic Acids Res. 2014 Jan;42(Database issue):D574-80. (PMID: 24243843)
Nucleic Acids Res. 2016 Jan 4;44(D1):D1202-13. (PMID: 26400175)
Emerg Infect Dis. 2013 Oct;19(10):1670-3. (PMID: 24048006)
J Glob Antimicrob Resist. 2020 Sep;22:175-176. (PMID: 32535077)
J Comput Chem. 2010 Mar;31(4):671-90. (PMID: 19575467)
Clin Infect Dis. 2017 Jan 15;64(2):134-140. (PMID: 27988485)
BMC Bioinformatics. 2012;13 Suppl 17:S6. (PMID: 23282219)
Drug Res (Stuttg). 2016 Sep;66(9):479-483. (PMID: 27409330)
Emerg Infect Dis. 2020 May;26(5):876-880. (PMID: 32310077)
Int J Adv Life Sci. 2012;4(1-2):21-32. (PMID: 24151543)
Am J Transplant. 2017 Jan;17(1):296-299. (PMID: 28029734)
J Med Chem. 2015 May 14;58(9):4066-72. (PMID: 25860834)
Curr Opin Infect Dis. 2018 Aug;31(4):334-340. (PMID: 29878905)
J Clin Microbiol. 2011 Sep;49(9):3139-42. (PMID: 21715586)
Nat Protoc. 2010 Apr;5(4):725-38. (PMID: 20360767)
Emerg Infect Dis. 2017 Jan;23(1):162-164. (PMID: 27983941)
PLoS Pathog. 2020 Oct 22;16(10):e1008921. (PMID: 33091071)
J Mol Model. 2012 May;18(5):1855-66. (PMID: 21850571)
Sci China Life Sci. 2018 Oct;61(10):1191-1204. (PMID: 30054833)
J Fungi (Basel). 2019 Jul 06;5(3):. (PMID: 31284576)
Biopharm Drug Dispos. 2011 Dec;32(9):530-5. (PMID: 22083890)
Indian J Med Microbiol. 2013 Jan-Mar;31(1):90-1. (PMID: 23508441)
Sci Rep. 2017 Mar 03;7:42717. (PMID: 28256516)
BMC Genomics. 2009 Mar 19;10:118. (PMID: 19298676)
In Silico Biol. 2006;6(1-2):43-7. (PMID: 16789912)
Front Public Health. 2014 Sep 16;2:145. (PMID: 25279369)
Nat Biotechnol. 2014 Jan;32(1):40-51. (PMID: 24406927)
Genomics. 2013 Jul;102(1):47-56. (PMID: 23628646)
Clin Infect Dis. 2017 Jan 15;64(2):141-143. (PMID: 27989986)
Arch Pathol Lab Med. 2020 Jan;144(1):107-114. (PMID: 31169997)
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. (PMID: 30476243)
J Biomol NMR. 1996 Dec;8(4):477-86. (PMID: 9008363)
Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. (PMID: 21534921)
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W294-7. (PMID: 22649060)
Nucleic Acids Res. 1999 Jan 1;27(1):29-34. (PMID: 9847135)
Nature. 2007 Oct 18;449(7164):804-10. (PMID: 17943116)
J Cheminform. 2011 Oct 07;3:33. (PMID: 21982300)
Comput Biol Chem. 2005 Oct;29(5):368-78. (PMID: 16213791)
Nucleic Acids Res. 2015 Jul 1;43(W1):W174-81. (PMID: 25883148)
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W229-32. (PMID: 18424796)
ChemMedChem. 2016 Jun 6;11(11):1117-21. (PMID: 27218427)
J Clin Microbiol. 2017 Oct;55(10):2996-3005. (PMID: 28747370)
Bioinformatics. 2010 Mar 1;26(5):680-2. (PMID: 20053844)
Nat Rev Drug Discov. 2004 Nov;3(11):935-49. (PMID: 15520816)
J Comput Chem. 2012 Dec 5;33(31):2451-68. (PMID: 22821581)
J Chem Theory Comput. 2012 Sep 11;8(9):3257-3273. (PMID: 23341755)
Med Mycol. 2019 Jan 1;57(1):1-12. (PMID: 30085270)
Brief Bioinform. 2020 Sep 25;21(5):1663-1675. (PMID: 31711157)
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. (PMID: 29126136)
mBio. 2020 Apr 28;11(2):. (PMID: 32345637)
J Chem Theory Comput. 2010 Feb 9;6(2):583-595. (PMID: 23620713)
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W363-7. (PMID: 15980490)
Front Chem. 2020 Aug 07;8:612. (PMID: 32850641)
فهرسة مساهمة: Keywords: Candida auris; Drug targets; In silico approach; MD simulation; Molecular docking; Potential drugs
تواريخ الأحداث: Date Created: 20230724 Latest Revision: 20230725
رمز التحديث: 20230725
مُعرف محوري في PubMed: PMC10361121
DOI: 10.1016/j.heliyon.2023.e17026
PMID: 37484251
قاعدة البيانات: MEDLINE
الوصف
تدمد:2405-8440
DOI:10.1016/j.heliyon.2023.e17026